Screener
Microbot Medical MBOT Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -32.9%+36.9pp | -27.6%+38.9pp | -32.4%+253pp | -31.9%+169pp | -69.8%+64.7pp | |
| Return on invested capital | -39.9%+49.7pp | -33%+45.9pp | -39.3%+794pp | -37.1%+176pp | -89.6%+156pp | |
| Liquidity | ||||||
| Current ratio | 18.6×+6.5× | 22.6×+6.4× | 23.3×+21.0× | 27.5×+23.9× | 12.1×+6.7× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $1.03+23.4% | $1.10+18.5% | $1.69+651% | $1.63+603% | $0.83+104% | |
| Valuation | ||||||
| Market capitalization | $102.09M-44.9% | $161.85M+208% | $134.32M+608% | $161.02M+991% | $93.13M+472% | |
| Price / book | 1.5×-4.6× | 2.2×+0.4× | 1.7×-3.6× | 2.1×-1.8× | 3.1×+0.4× |
FAQ
- Where do Microbot Medical's ratios come from?
- Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
